Alberto Zacarias is Senior Director of Innovation and a member of the Site Leadership Team at AbbVie Biotherapeutics, AbbVie’s Center of Innovation in oncology R&D located in Redwood City, CA. His extensive background in new product planning, innovation, and portfolio management positions Alberto well for successfully defining and leading initiatives to maximize the value of AbbVie Biotherapeutics as a site of R&D excellence. Prior to joining AbbVie in 2013, Alberto was President of The Zantos Group, a biopharmaceutical business consultancy providing new product planning and portfolio management advice to pharmaceutical and biotechnology companies. Before founding The Zantos Group, he held positions of increasing responsibility in new product planning and portfolio and innovation management at Nektar Therapeutics, Johnson & Johnson, Alza Pharmaceuticals, and Searle Pharmaceuticals (now Pfizer). He received his MBA, with Honors, from the University of Chicago in Finance and Marketing, and a BS in Biomedical Engineering from Boston University.